DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s13402-024-00960-8, but it redirected us to https://link.springer.com/article/10.1007/s13402-024-00960-8. The analysis below is for the second page.

Title[redir]:
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine | Cellular Oncology
Description:
Cancer is a highly heterogeneous disease, and thus treatment responses vary greatly between patients. To improve therapy efficacy and outcome for cancer patients, more representative and patient-specific preclinical models are needed. Organoids and tumoroids are 3D cell culture models that typically retain the genetic and epigenetic characteristics, as well as the morphology, of their tissue of origin. Thus, they can be used to understand the underlying mechanisms of cancer initiation, progression, and metastasis in a more physiological setting. Additionally, co-culture methods of tumoroids and cancer-associated cells can help to understand the interplay between a tumor and its tumor microenvironment. In recent years, tumoroids have already helped to refine treatments and to identify new targets for cancer therapy. Advanced culturing systems such as chip-based fluidic devices and bioprinting methods in combination with tumoroids have been used for high-throughput applications for personalized medicine. Even though organoid and tumoroid models are complex in vitro systems, validation of results in vivo is still the common practice. Here, we describe how both animal- and human-derived tumoroids have helped to identify novel vulnerabilities for cancer treatment in recent years, and how they are currently used for precision medicine.

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, cancer, article, google, scholar, cas, cell, organoids, central, tumor, cells, models, tumoroids, drug, organoid, model, httpsdoiorgs, human, patientderived, treatment, response, research, culture, nat, tumoroid, tissue, patients, coculture, heterogeneity, medicine, therapy, pdts, stem, tme, screening, vivo, types, primary, personalized, vitro, modeling, lines, systems, study, wang, immune, lung, disease, cultures, colorectal,

Topics {✒️}

gov/bill/117th-congress/senate-bill/5002/ cdh3-β-catenin-laminin signaling axis gov/ccg/research/functional-genomics/hcmi ionizing-radiation-induced intestinal injury pd-1/pd-l1 inhibitors article google scholar patient-specific immune-enhanced organoids air–liquid interface promotes patient-derived organoid-fibroblast model cyclodextrin-lgk974 inclusion complexes patient-derived organoid pharmacotyping patient-derived organoid serves ultra-high-throughput screening thiol-reactive organoid barcoding cre recombinase-based system single-cell transcriptomic profiles generating patient-derived gliomas ovarian cancer-specific genes patient-derived xenograft models establishing patient-derived organoids patient-specific preclinical models patient-derived pancreatic cancer multi-organ chip-based systems patient-derived organoid models patient-derived tumor antigen multiparametric microscopy-based readout xenograft-derived tumoroid screen patient-specific precision medicine proving inter-patient heterogeneity orthotopic patient-derived xenograft muscle-invasive bladder cancer providing high-level feedback patient-derived cancer organoids human-derived 3d models patient-specific drug responses confirmed lineage-dependent differences high-throughput drug screens patient-derived lung tumoroids reversibly dormant basal-luminal patient-specific colonoscopy images jak/stat inflammatory signaling air-liquid interface patient-derived cell lines wnt-induced phenotypic switch patient-derived spheroid cultures chip-based fluidic devices patient-derived tumor organoids testing patient-specific responses differential pre-malignant programs high-grade glioma organoids

Questions {❓}

Straume, Are 90% of deaths from cancer caused by metastases?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
         description:Cancer is a highly heterogeneous disease, and thus treatment responses vary greatly between patients. To improve therapy efficacy and outcome for cancer patients, more representative and patient-specific preclinical models are needed. Organoids and tumoroids are 3D cell culture models that typically retain the genetic and epigenetic characteristics, as well as the morphology, of their tissue of origin. Thus, they can be used to understand the underlying mechanisms of cancer initiation, progression, and metastasis in a more physiological setting. Additionally, co-culture methods of tumoroids and cancer-associated cells can help to understand the interplay between a tumor and its tumor microenvironment. In recent years, tumoroids have already helped to refine treatments and to identify new targets for cancer therapy. Advanced culturing systems such as chip-based fluidic devices and bioprinting methods in combination with tumoroids have been used for high-throughput applications for personalized medicine. Even though organoid and tumoroid models are complex in vitro systems, validation of results in vivo is still the common practice. Here, we describe how both animal- and human-derived tumoroids have helped to identify novel vulnerabilities for cancer treatment in recent years, and how they are currently used for precision medicine.
         datePublished:2024-05-28T00:00:00Z
         dateModified:2024-05-28T00:00:00Z
         pageStart:1
         pageEnd:26
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s13402-024-00960-8
         keywords:
            Cancer
            3D models
            Preclinical models
            Organoids
            Tumoroids
            Precision medicine
            Co-culture
            Bioprinting
            Fluidic devices
            Cancer Research
            Biomedicine
            general
            Pathology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig3_HTML.png
         isPartOf:
            name:Cellular Oncology
            issn:
               2211-3436
               2211-3428
            volumeNumber:48
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jessica Kalla
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Janette Pfneissl
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Theresia Mair
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Loan Tran
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:Ludwig Boltzmann Institute Applied Diagnostics
                     address:
                        name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gerda Egger
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:Ludwig Boltzmann Institute Applied Diagnostics
                     address:
                        name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:Medical University of Vienna
                     address:
                        name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
      description:Cancer is a highly heterogeneous disease, and thus treatment responses vary greatly between patients. To improve therapy efficacy and outcome for cancer patients, more representative and patient-specific preclinical models are needed. Organoids and tumoroids are 3D cell culture models that typically retain the genetic and epigenetic characteristics, as well as the morphology, of their tissue of origin. Thus, they can be used to understand the underlying mechanisms of cancer initiation, progression, and metastasis in a more physiological setting. Additionally, co-culture methods of tumoroids and cancer-associated cells can help to understand the interplay between a tumor and its tumor microenvironment. In recent years, tumoroids have already helped to refine treatments and to identify new targets for cancer therapy. Advanced culturing systems such as chip-based fluidic devices and bioprinting methods in combination with tumoroids have been used for high-throughput applications for personalized medicine. Even though organoid and tumoroid models are complex in vitro systems, validation of results in vivo is still the common practice. Here, we describe how both animal- and human-derived tumoroids have helped to identify novel vulnerabilities for cancer treatment in recent years, and how they are currently used for precision medicine.
      datePublished:2024-05-28T00:00:00Z
      dateModified:2024-05-28T00:00:00Z
      pageStart:1
      pageEnd:26
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s13402-024-00960-8
      keywords:
         Cancer
         3D models
         Preclinical models
         Organoids
         Tumoroids
         Precision medicine
         Co-culture
         Bioprinting
         Fluidic devices
         Cancer Research
         Biomedicine
         general
         Pathology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-00960-8/MediaObjects/13402_2024_960_Fig3_HTML.png
      isPartOf:
         name:Cellular Oncology
         issn:
            2211-3436
            2211-3428
         volumeNumber:48
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jessica Kalla
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Janette Pfneissl
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Theresia Mair
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Loan Tran
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:Ludwig Boltzmann Institute Applied Diagnostics
                  address:
                     name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gerda Egger
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Department of Pathology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:Ludwig Boltzmann Institute Applied Diagnostics
                  address:
                     name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:Medical University of Vienna
                  address:
                     name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cellular Oncology
      issn:
         2211-3436
         2211-3428
      volumeNumber:48
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical University of Vienna
      address:
         name:Department of Pathology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Pathology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Pathology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Pathology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Ludwig Boltzmann Institute Applied Diagnostics
      address:
         name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Pathology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Ludwig Boltzmann Institute Applied Diagnostics
      address:
         name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jessica Kalla
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Pathology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Janette Pfneissl
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Pathology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Theresia Mair
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Pathology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Loan Tran
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Pathology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:Ludwig Boltzmann Institute Applied Diagnostics
            address:
               name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Gerda Egger
      affiliation:
            name:Medical University of Vienna
            address:
               name:Department of Pathology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:Ludwig Boltzmann Institute Applied Diagnostics
            address:
               name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:Medical University of Vienna
            address:
               name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, Medical University of Vienna, Vienna, Austria
      name:Department of Pathology, Medical University of Vienna, Vienna, Austria
      name:Department of Pathology, Medical University of Vienna, Vienna, Austria
      name:Department of Pathology, Medical University of Vienna, Vienna, Austria
      name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
      name:Department of Pathology, Medical University of Vienna, Vienna, Austria
      name:Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
      name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

External Links {🔗}(1214)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

6.71s.